Are You Ready for New Approaches and Methods?
In this FDA News hosted webinar. Regulatory Compliance Associates®, Seyed Khorashahi, Executive Vice President and CTO, shares the most likely medical device inspection scenarios and practical preparation strategies for unannounced FDA medical device inspections.
The FDA developed novel approaches to conducting inspections during the pandemic, including remote record reviews and other virtual activities. And it will undoubtedly continue using the most effective of these going forward, even post-pandemic.
Prepare for all possibilities — traditional on-site, fully remote, or hybrid — with this webinar.
Webinar Takeaways:
- How to use a risk-based approach to inspection preparations
- How to prepare by establishing inspection hosting procedures and practicing readiness
- What to expect from the time the FDA investigators arrive until they leave
- What to do after the inspection
- What regulators may look for going forward into 2022
- What alternative tools the FDA may use for oversight of regulated products
To begin the Regulatory Compliance Associates® scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage.